The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature
Abstract
We conducted a prospective, randomized, multicenter study comparing fluconazole and amphotericin B in the treatment of candidal infections. One hundred and sixty-four patients (60 of whom were neutropenic) with documented or presumed invasive candidiasis were assigned to treatment with either fluconazole (400 mg daily) or amphotericin B (25-50 mg daily; 0.67 mg/kg daily for neutropenic patients). Clinical response and survival rates were assessed at 48 hours, after 5 days, and at the end of therapy. Overall response rates to fluconazole and amphotericin B were similar (66% and 64%, respectively). There were no differences in response as related to site of infection, pathogen, time to defervescence, relapse, or survival rates between the groups. Adverse effects were more frequent with amphotericin B (35%) than with fluconazole (5%; P < .0001). The results of this study confirm that fluconazole is as effective as but better tolerated than amphotericin B in the treatment of candidal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,009
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Pizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679
Predominant pathogens in hospital infections
Jarvis, W. R., & Martone, W. J. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.suppl_a.19 · Cited by 578
Empiric antifungal therapy in febrile granulocytopenic patients
(1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90441-5 · Cited by 378
Nguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363
Haley, L. D. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/36.3.227 · Cited by 216
Anaissie, E. J., Vartivarian, S. E., Abi-Said, D., Uzun, O., Pinczowski, H., Kontoyiannis, D. P., Khoury, P., Papadakis, K., Gardner, A., Raad, I. I., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80072-6 · Cited by 188
Self-citationClinical Aspects of Fungal Infection in Organ Transplant Recipients
Hibberd, P. L., & Rubin, R. H. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.supplement_1.s33 · Cited by 138
Nosocomial fungemia in a large community teaching hospital.
Harvey, R. L., & Myers, J. P. (1987) · PubMed · Cited by 132
Emergence of a new opportunistic pathogen, Candida lusitaniae
Blinkhorn, R., Adelstein, D. J., & Spagnuolo, P. J. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.2.236-240.1989 · Cited by 126
Indications for Therapy for Fungemia in Postoperative Patients
Solomkin, J. S. (1982) · Archives of Surgery · doi:10.1001/archsurg.1982.01380340008003 · Cited by 105
Fluconazole andCandida kruseiFungemia
Persons, D. A., Laughlin, M. A., Tanner, D., Perfect, J. R., Gockerman, J. P., & Hathorn, J. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251814 · Cited by 98
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections
Wout, J. W. V., Mattie, H., & van Forth, R. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/21.5.665 · Cited by 89
Kujath, P., Boos, C., Lerch, K., & Kochendörfer, P. (1993) · Infection · doi:10.1007/bf01728917 · Cited by 83
Nguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.22.2429 · Cited by 78
A clinical study of fluconazole for the treatment of deep mycoses
IKEMOTO, H. (1989) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(89)90143-0 · Cited by 67
Secondary mycosis in surgery: Treatment with fluconazole
Kujath, P., & Lerch, K. (1989) · Infection · doi:10.1007/bf01646895 · Cited by 49
Treatment of Candidemia in Critically Ill Surgical Patients with Intravenous Fluconazole
Nolla‐Salas, J., Leon, C. C. D., Torres-Rodrı́guez, J. M., Martin, E., & Sitges‐Serra, A. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.4.952 · Cited by 38
Cited by
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Fidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Metadata
- Authors
- Anaissie, E. J., Darouiche, R. O., Abi-Said, D., Uzun, O., Mera, J., Gentry, L. O., Williams, T., Kontoyiannis, D. P., Karl, C. L., & Bodey, G. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-11-01
- Volume
- 23
- Issue
- 5
- Pages
- 964-972
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2094616030
- Cited by
- 278
- References
- 24
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.